Metabolic syndrome in the elderly
https://doi.org/10.15829/1560-4071-2025-6542
Abstract
The article analyzes modern concepts of the pathogenesis, diagnosis and impact on the prognosis of metabolic syndrome in the elderly. The prevalence of metabolic syndrome in this category of patients is analyzed. An overview of modern potential of non-drug and drug therapy of metabolic syndrome is given, taking into account the requirements for the management of geriatric patients.
About the Authors
E. N. Dudinskaya
Pirogov Russian National Research Medical University
Russian Federation
Competing Interests:
Russian Federation
Moscow
Competing Interests:
None
L. V. Matchekhina
Pirogov Russian National Research Medical University
Russian Federation
Competing Interests:
Russian Federation
Moscow
Competing Interests:
None
Yu. S. Onuchina
Pirogov Russian National Research Medical University
Russian Federation
Competing Interests:
Russian Federation
Moscow
Competing Interests:
None
References
1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-53. doi:10.1002/(SICI)1096-9136(199807)15:7<535::AID-DIA670>3.0.CO;2-Q.
2. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome — A new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469-80. doi:10.1111/j.1464-5491.2006.01858.x.
3. Sinclair A, Viljoen A. The metabolic syndrome in older persons. Clin Geriatr Med. 2010;26(2):261-74. doi:10.1016/j.cger.2010.02.011.
4. Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018;20(2):12. doi:10.1007/s11906-018-0812-z.
5. Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016;126(1):12-22. doi:10.1172/JCI77812.
6. Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127(1):1-4. doi:10.1172/JCI92035.
7. Münzberg H, Morrison CD. Structure, production and signaling of leptin. Metabolism. 2015;64(1):13-23. doi:10.1016/j.metabol.2014.09.010.
8. Bermúdez VJ, Rojas E, Toledo A, et al. Single-nucleotide polymorphisms in adiponectin, AdipoR1, and AdipoR2 genes: insulin resistance and type 2 diabetes mellitus candidate genes. Am J Ther. 2013;20(4):414-21. doi:10.1097/MJT.0b013e318235f206.
9. DeVallance E, Li Y, Jurczak MJ, et al. The Role of NADPH Oxidases in the Etiology of Obesity and Metabolic Syndrome: Contribution of Individual Isoforms and Cell Biology. Antioxid Redox Signal. 2019;31(10):687-709. doi:10.1089/ars.2018.7674.
10. Luna P, Guarner V, Farías JM, et al. Importance of Metabolic Memory in the Development of Vascular Complications in Diabetic Patients. J Cardiothorac Vasc Anesth. 2016;30(5): 1369-78.doi:10.1053/j.jvca.2016.02.008.
11. Jankovic A, Korac A, Buzadzic B, et al. Redox implications in adipose tissue (dys)function — A new look at old acquaintances. Redox Biol. 2015;6:19-32. doi:10.1016/j.redox.2015.06.018.
12. Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018;14(9):513-37. doi:10.1038/s41574-018-0062-9.
13. Frazier TH, DiBaise JK, McClain CJ. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN J Parenter Enteral Nutr. 2011;35(5 Suppl):14S-20S. doi:10.1177/0148607111413772.
14. Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110(22):9066-71. doi:10.1073/pnas.1219451110.
15. Pols TW, Noriega LG, Nomura M, et al. The bile acid membrane receptor TGR5: a valuable metabolic target. Dig Dis. 2011;29(1):37-44. doi:10.1159/000324126.
16. Michka VB, Vertkin AL, Vardaev LI, et al. Expert Consensus on an Interdisciplinary Approach to the Management, Diagnosis, and Treatment of Patients with Metabolic Syndrome. Cardiovascular Therapy and Prevention. 2013;12(6):41-82. (In Russ.)
17. Tkacheva ON, Tutelyan VA, Shestopalov AE, et al. Nutritional insufficiency (malnutrition) in older adults. Clinical recommendations. Russian Journal of Geriatric Medicine. 2021;(1):15-34. (In Russ.) doi:10.37586/2686-8636-1-2021-15-34.
18. Tkacheva ON, Kotovskaya YuV, Runikhina NK, et al. Clinical Guidelines on Frailty. Russian Journal of Geriatric Medicine. 2025;(1):6-48. (In Russ.) doi:10.37586/2686-8636-1-2025-6-48.
19. Algorithms of specialized medical care for patients with diabetes mellitus. Edited by I. I. Dedov, M. V. Shestakova, O. Yu. Sukhareva. 12th issue. M.; 2025. (In Russ.)
20. Frías JP, Davies MJ, Rosenstock J, et al.; SURPASS-2 Investigators. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021;385(6):503-15. doi:10.1056/NEJMoa2107519.
21. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/ AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):3168-209. doi:10.1016/j.jacc.2018.11.002. Erratum in: J Am Coll Cardiol. 2019;73(24):3234-7. doi:10.1016/j.jacc.2019.05.012.
22. Kotovskaya Yu V. Elderly patient with arterial hypertension: focus on individualization of therapy. Therapy. 2022. 8(9):145-51. (In Russ.) doi:10.18565/therapy.2022.9.145-151.
23. O’Mahony D, Cherubini A, Guiteras AR, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med. 2023;14(4):625-32. doi:10.1007/s41999-023-00777-y. Erratum in: Eur Geriatr Med. 2023;14(4):633. doi:10.1007/s41999-023-00812-y.
Review
For citations:
Dudinskaya E.N., Matchekhina L.V., Onuchina Yu.S. Metabolic syndrome in the elderly. Russian Journal of Cardiology. 2025;30(1S):6542. (In Russ.) https://doi.org/10.15829/1560-4071-2025-6542
Views:
286
Email this article 